Cita APA (7a ed.)
Liu, P., Chen, Y., Chen, W., Ho, C., & Lee, C. (2026). Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series. Current Oncology, 33(6), 311-323.
Cita Chicago Style (17a ed.)
Liu, Po-Tsen, Yi-Lin Chen, Wan-Li Chen, Chung-Liang Ho, y Chun-Hui Lee. "Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series." Current Oncology 33, no. 6 (2026): 311-323.
Cita MLA (9a ed.)
Liu, Po-Tsen, et al. "Acquired ROS1 Intragenic Rearrangements as a Resistance Mechanism in EGFR -Mutant Non-Small Cell Lung Cancer: A Case Series." Current Oncology, vol. 33, no. 6, 2026, pp. 311-323.
Precaución: Estas citas no son 100% exactas.